mynth
11/2023100%

Medicx Health acquired by Optimizerx

UNITED STATES Software / AdTech EV $50–150M

Context

OptimizeRx agreed to acquire 100% of Medicx Health. The operation will be funded through a combination of existing cash, short-term investments, and proceeds from a new $40 million credit facility provided by Blue Torch Capital. Certain members of Medicx's management, including founder and CEO, committed to reinvesting approximately $10.5 million of their transaction proceeds into OptimizeRx common stock, aligning their interests with the combined entity's success. The strategic rationale centres on creating the most comprehensive healthcare marketing platform in the US by combining OptimizeRx's HCP-focused DAAP platform with Medicx's consumer-focused Micro-Neighborhood® Targeting Platform — thereby addressing both key stakeholders in pharmaceutical marketing (doctors and patients) through a single integrated technology ecosystem.

Medicx Health, which reported an EBITDA margin of [members only] in 2022, is valued in this transaction at an EV/EBITDA multiple of [members only].

-> Deep-dive in TMT (Tech, Media, Telecom) market trends

Target

Medicx Health is a Scottsdale, Arizona-based healthcare consumer-focused omnichannel marketing and analytics company serving hundreds of life sciences brands. The company's core proprietary technology is its patented Micro-Neighborhood® Targeting Platform, built on its MX# advanced identity resolution technology, which enables highly precise, privacy-compliant targeting of both healthcare consumers and healthcare providers (HCPs) at the neighbourhood level. Medicx's platform supports life sciences brand and agency clients across the full commercial marketing cycle — from audience planning and omnichannel campaign execution (spanning advanced TV, programmatic digital display and video, social, digital radio) to closed-loop performance measurement, all within a single privacy-compliant environment.

Ent. Value

$50–150M

Equity Value

[members only]

Multiples

EV / Revenue

2x–6x

EV / EBITDA

[members only]

EV / EBIT

[members only]

Historical Financials (USD)

Year
Rev
EBITDA
EBIT
2022
$25–50M
[members only]
[members only]
2021
$25–50M
[members only]
[members only]

Similar deals in Software

Similar deals in Software
DateAcquirerTargetCountrySector
12/2023LEONARD GREEN & PARTNERS / HG CAPITALIRIS SOFTWARE GROUPUNITED KINGDOMERP, HR & Finance
12/2023CVCSOGELINKFRANCEConstruction / Real Estate
11/2023KEYSIGHT TECHNOLOGIESESI GROUPFRANCEEngineering & Design Software
11/2023OCEANSOUND PARTNERSMESSAGE BROADCASTUNITED STATESMarTech
11/2023DEVOLVER DIGITALSYSTEM ERA SOFTWORKSUNITED STATESGaming & Consumer Apps
11/2023PSG EQUITYDIAPASONFRANCEERP, HR & Finance
11/2023ARCHIMEDINSTEMUNITED KINGDOMHealthcare
11/202321 INVESTCONEXFRANCEIndustry-Specific Software
10/2023SANDVIKESCOGERMANYSupply Chain & Ops
10/2023CAPZATRAVELSOFTFRANCETravel & Hospitality

REFERENCES

Valuation range: EV $50–150M

Revenue range: $25–50M

EV/Revenue range: 2x - 6x

Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of Medicx Health by Optimizerx are reserved for mynth community members. Register for free to unlock full data.

Authors: This transaction was contributed by a verified mynth contributor and cross-checked against available transaction documents and official company communications.

FAQ

What transaction does this page cover?

This page covers Optimizerx’s acquisition of 100% of Medicx Health, an American company specialised in AdTech, in 2023.

How was the acquisition of Medicx Health by Optimizerx valued, and what multiples were paid?

mynth displays the transaction’s enterprise value within the $50–150M band and its EV/revenue multiple within the 2x - 6x range. Exact figures are available to members.

What was Medicx Health’s revenue at the time of the deal?

At the time of the transaction, Medicx Health’s annual revenue was estimated within the $25–50M range (FY 2022). Detailed financial figures are available to members.

What sources support the information on this transaction?

The details of this transaction are sourced directly from the official corporate announcement published on the parties’ institutional website, ensuring primary-source verification of the closing and perimeter.

What is mynth?

mynth is the first free M&A database dedicated to Small & Mid-Cap transactions. We centralize Enterprise Values, revenue multiples, EBITDA multiples and transaction financials that are typically locked behind five-figure subscriptions on platforms like Capital IQ or Mergermarket. On mynth, searching and browsing deals is completely free. Our mission is simple: make professional-grade valuation intelligence accessible to every M&A advisor, independent consultant, Private Equity professional and student, without the burden of expensive annual licenses.